Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Market Closed - BME
Other stock markets
 16:35:26 26/04/2024 BST 		5-day change 1st Jan Change
2 EUR +0.91% Intraday chart for Oryzon Genomics S.A. +5.60% +5.93%
04-22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI
04-08 ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer CI

Chart calendar Oryzon Genomics S.A.

8f75d947caba2fa09d53e816a21.uuhWqEdOR-bdxcJM37JjRApj8TUwRvKX5YDFNqX-OzY.9pk6xgt9FrSr_PIEseYSBztbn0JHBJvIl8Hwbs-Wc1iJpAn6PS0U1e-Eiw~816a2985e261672d712e85c010fc297c

Upcoming events on Oryzon Genomics S.A.

29/04/2024 LSX World Congress
02/05/2024 Q1 2024 Earnings Release (Projected)
23/07/2024 Q2 2024 Earnings Release (Projected)
24/10/2024 Q3 2024 Earnings Release (Projected)
02/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Oryzon Genomics S.A.

21/04/2024 Swiss Biotech Day
15/04/2024 Van Lanschot Kempen Life Sciences Conference
17/03/2024 BioEurope Spring Conference
27/02/2024 European Life Sciences CEO Forum
26/02/2024 19:28 Q4 2023 Earnings Release
13/02/2024 Bio Neuroscience Conference
06/02/2024 Keystone Symposia Epigenetic Mechanisms and Cancer Treatment conference
29/01/2024 Invest Securities Biomed Forum
25/01/2024 15:00 Investor Meeting - Key Opinion Leader
09/01/2024 22:30 Biotech Showcase
08/01/2024 01:30 PORTICO Study Phase IIb Results Call
07/01/2024 LifeSci Partners Corporate Access Event
07/01/2024 JPMorgan Healthcare Conference
07/01/2024 21:00 Sachs Neuroscience Innovation Forum
13/11/2023 BIO Europe Conference
12/11/2023 LSX Investival Showcase
05/11/2023 Bio-Europe Conference
27/10/2023 17:12 Q3 2023 Earnings Release
19/10/2023 European Society for Medical Oncology Congress
12/10/2023 15:00 Roth Healtcare Opportunities Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR		Released
Forecast
Spread 		6,78
7,03
-3.6%		0,00
3,26
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
3,60
- 		0,00
0,00
-
EBITDA
Million EUR		Released
Forecast
Spread 		-2,77
-4,68
40.79%		-3,68
-4,27
13.78%		-4,14
-4,09
-1.31%		-6,87
-5,80
-18.38%		-5,32
-4,97
-7.22%		0,00
-5,25
-
EBIT
Million EUR		Released
Forecast
Spread 		-10,2
-10,5
2.81%		-3,97
-4,44
10.6%		-4,34
-4,23
-2.69%		-17,6
-17,8
1.13%		-21,4
-13,4
-59.54%		-19,2
-12,1
-59.27%
Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-3,71
-6,35
41.53%		-4,58
-5,13
10.84%		-4,34
-5,18
16.31%		-6,94
-7,36
5.67%		-5,49
-6,08
9.63%		-4,63
-6,12
24.26%
Net income
Million EUR		Released
Forecast
Spread 		-1,18
-4,15
71.63%		-3,81
-3,24
-17.63%		-3,43
-3,86
11.06%		-4,64
-5,01
7.36%		-4,23
-4,01
-5.54%		-3,42
-3,56
4.05%
EPS
EUR		Released
Forecast
Spread 		-0,03
-0,11
72.64%		-0,09
-0,10
7.94%		-0,07
-0,08
21.6%		-0,09
-0,09
6.03%		-0,08
-0,08
1.72%		-0,06
-0,06
-0.56%
Announcement Date15/02/1924/02/2023/02/2107/02/2217/02/2326/02/24

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2021 Q2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 S2
Net sales
Million EUR		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
-
0,00


0,00


0,00


0,00


0,00


0,00

EBIT
Million EUR		Released
Forecast
Spread 		-1,62
-2,20
26.21%		-7,69
-2,10
-266.11%


-3,32
-2,40
-38.24%


-5,14
-4,71
-9.23%		-14,2
-2,60
-445.56%


-1,76
-3,46
49.2%		-3,36
-3,90
13.77%		-5,00
-6,02
17%		-5,89
-5,26
-12.11%
-4,60




-4,84
-5,61
13.67%		-2,47


-4,24
-5,34
20.49%
-4,55


-4,92


-5,20





-5,51




Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-1,94
-2,60
25.21%		-2,16
-2,10
-2.62%		-1,57
-2,36
33.25%		-3,32
-2,90
-14.4%		-1,54
-1,50
-2.75%		-2,12
-2,30
7.97%		-3,50
-3,40
-2.85%		-1,66
-2,49
33.31%		-1,75
-3,14
44.25%		-3,44
-4,10
16.18%		-0,69
-2,90
76.06%		-1,49
-2,62
43.12%
-5,00

-1,61
-3,17
49%		-1,18
-1,99
40.78%		-3,27


-0,78
-2,34
66.66%
-2,43


-1,70


-1,80


-3,20


-1,90


-3,20

Net income
Million EUR		Released
Forecast
Spread 		-1,97
-0,90
-119.06%		-1,31
-2,10
37.76%		0,80
-2,27
135.16%		-1,02
-2,90
64.87%		-1,57
-1,42
-11.05%		-2,06
-2,34
11.79%		-3,59
-3,40
-5.45%		-1,72
-2,54
32.02%		0,34
-1,87
118.18%		-1,30
-4,10
68.33%		-0,63
-2,94
78.71%		-2,30
-2,61
11.95%
-4,90

-1,61
-2,94
45.01%		1,04
-1,48
170.31%		-0,57


-1,06
-2,40
55.76%
-1,64


-1,79


-1,88


-3,20


-2,01


-1,20

EPS
EUR		Released
Forecast
Spread 		-0,05
0,00
- 		-0,03
0,00
- 		0,02
-0,04
140.05%		-0,02
-0,10
83.18%		-0,03
-0,03
-2.72%		-0,03
-0,04
20.55%		-0,07
-0,10
29.99%		-0,03
-0,05
37.23%		0,01
-0,04
124.86%		-0,03
-0,10
70.55%		-0,01
-0,05
79.74%		-0,05
-0,05
1.28%
-0,10

-0,03
-0,06
50.31%		0,02
-0,03
165.67%		-0,01


-0,02
-0,04
55.05%
-0,03


-0,03


-0,03


-0,10


-0,03


0,00

Announcement Date24/02/2022/07/2029/07/2129/07/2128/10/2107/02/2207/02/2205/05/2222/07/2222/07/2202/11/2217/02/23-10/05/2324/07/2324/07/2327/10/23------

Upcoming sector events for Oryzon Genomics S.A.

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Oryzon Genomics S.A.

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Calendar Oryzon Genomics S.A.